Clinical Trial Update: Study of Metabolites Markers in Adjuvant Breast Cancer

View source ↗

Summary

A completed clinical trial evaluating metabolite markers in the adjuvant setting for breast cancer to identify potential prognostic or predictive biomarkers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Breast Neoplasms | Status: COMPLETED